Depletion of muscle glycogen is considered a limiting performance factor during prolonged exercise, whereas the role of the intramyocellular lipid (IMCL) pool is not yet fully understood. We examined 1) intramyocellular glycogen and lipid utilization during prolonged exercise, 2) resynthesis of muscle glycogen and lipids during recovery, and 3) changes in glycogen content between nonexercising and exercising muscles during recovery. Subjects ran on a treadmill at submaximal intensity until exhaustion. Glycogen concentrations were assessed in thigh, calf, and nonexercising forearm muscle, and IMCL content was measured in soleus muscle using magnetic resonance spectroscopy techniques. At the time of exhaustion, glycogen depletion was 2-fold greater in calf than in thigh muscles, but a significant amount of glycogen was left in both leg muscles. The glycogen concentration in nonexercising forearm muscle decreased during the initial 5 h of recovery to 73% of the baseline value. During the exercise, the IMCL content decreased to 67% and subsequently during recovery increased to 83% of the baseline value. In summary, we found during prolonged running 1) significantly greater muscle glycogen utilization in the calf muscle group than in the thigh muscle group, 2) significant utilization of IMCL in the soleus muscle, and 3) a decrease in glycogen content in nonexercising muscle and an increase in glycogen content in recovering muscles during the postexercise phase. These latter data are consistent with the hypothesis that there is transfer of glycogen by the glucose3lactate and the glucose3alanine cycle from the resting muscle (forearm) to recovering muscles (thigh and calf) after running exercise . (J Clin Endocrinol Metab 85: 748 -754, 2000) T HE ROLE OF carbohydrates as a fuel for muscles during prolonged exercise has been studied intensively (1-5). Depletion of muscle glycogen content is considered a limiting factor for performance during prolonged exercise (1) and is related to fatigue from intense cycling (6). Other data show that prolonged running to exhaustion did not lead to comparable low muscle glycogen concentrations (7). Studies of the effects of various diets, glucose, and insulin infusion protocols during the recovery period following prolonged exercise of submaximal intensity have shown that the rate of glycogen resynthesis under all of these conditions is 3-5 times slower than the rate of glycogen synthesis after a short period of high intensity exercise (8 -16). Running as a model for eccentric muscle contraction was shown to produce muscle damage (17, 18), which affects exercise performance and impairs the structural and energetic recovery of muscle tissue after the exercise.
centration in nonexercising forearm muscle decreased during the initial 5 h of recovery to 73% of the baseline value. During the exercise, the IMCL content decreased to 67% and subsequently during recovery increased to 83% of the baseline value. In summary, we found during prolonged running 1) significantly greater muscle glycogen utilization in the calf muscle group than in the thigh muscle group, 2) significant utilization of IMCL in the soleus muscle, and 3) a decrease in glycogen content in nonexercising muscle and an increase in glycogen content in recovering muscles during the postexercise phase. These latter data are consistent with the hypothesis that there is transfer of glycogen by the glucose3lactate and the glucose3alanine cycle from the resting muscle (forearm) to recovering muscles (thigh and calf) after running exercise . (J Clin Endocrinol Metab 85: 748 -754, 2000) T HE ROLE OF carbohydrates as a fuel for muscles during prolonged exercise has been studied intensively (1) (2) (3) (4) (5) . Depletion of muscle glycogen content is considered a limiting factor for performance during prolonged exercise (1) and is related to fatigue from intense cycling (6) . Other data show that prolonged running to exhaustion did not lead to comparable low muscle glycogen concentrations (7) . Studies of the effects of various diets, glucose, and insulin infusion protocols during the recovery period following prolonged exercise of submaximal intensity have shown that the rate of glycogen resynthesis under all of these conditions is 3-5 times slower than the rate of glycogen synthesis after a short period of high intensity exercise (8 -16) . Running as a model for eccentric muscle contraction was shown to produce muscle damage (17, 18) , which affects exercise performance and impairs the structural and energetic recovery of muscle tissue after the exercise.
Hepatic glycogen mobilization and gluconeogenesis also play an important role as a source of glucose for the working muscle and glycogen replenishment of active and recovering muscle (19 -21) . However, the possible redistribution of glycogen stores from noncontracting to contracting muscles during both exercise and recovery is still questioned (3, (22) (23) (24) (25) (26) . According to the proposed model, glycogenolysis coupled to nonaerobic glycolysis in nonactive muscles would provide the substrates for glucose production through gluconeogenesis in the liver and kidney, which could than be channeled to preexercised muscle for glycogen repletion during recovery from exercise Although it has been demonstrated that fuel utilization shifts from carbohydrates to lipids with increasing duration of submaximal exercise (27) (28) (29) , the specific contribution of the intramyocellular lipid (IMCL) pool as energy substrate also remains to be determined. Dynamic changes in IMCL during prolonged exercise and subsequent recovery have been evaluated by using an invasive approach. Some studies showed a significant depletion of intramuscular lipid stores during the exercise and an increase in these stores during the recovery phase (30 -33) . Other studies found no changes in the intramuscular triglycerides after shorter exercise tests with alternating exercise intensities (34, 35) .
Now that recent studies have presented and validated the nuclear magnetic resonance (NMR) spectroscopy methods for noninvasive quantification of IMCL (36, 37) and glycogen (38) contents, the present study was designed to examine 1) intracellular glycogen and lipid utilization in different muscle groups during prolonged exercise, 2) resynthesis of glycogen and IMCL of different muscles during recovery from exercise, and 3) whether there is redistribution of glycogen between nonexercising and exercising muscles during recovery.
Subjects and Methods Subjects
Nine (seven males and two females) trained subjects (body mass index, 24.3 Ϯ 1.2 kg/m 2 ; VO 2 peak, 54.2 Ϯ 2.7 mL O 2 /kg⅐min) underwent the exercise protocol, and three of them [body mass index, 25.7 Ϯ 3 kg/m 2 ; VO 2 peak (maximal oxygen consumption), 52.7 Ϯ 2.5 mL O 2 / kg⅐min] underwent an additional control protocol. For 3 days before the study, subjects received an isocaloric diet consisting of 60% carbohydrates, 20% fat, and 20% proteins and were instructed not to participate in strenuous physical exercise. Experimental procedures were carried out in accordance with the guidelines of the human investigation committee of Yale University School of Medicine. All subjects gave informed consent after the purpose, nature, and potential risks of the study were explained to them.
Peak oxygen uptake test
Maximal aerobic power was determined during a preliminary running treadmill (series 2000 Treadmill, Marquette, WI) test session 10 days before the running experiment using incremental speeds (starting at 2.5 km/h 1 and ϩ1.0 km/h every minute) and grades (starting at 0°a nd ϩ2°every minute) until exhaustion. Oxygen uptake was measured by indirect calorimetry based on continuous breath by breath analysis of expired gas and measurement of minute ventilation (Vmax29 Metabolic Monitor, Sensormedics, CA). Heart rate was monitored during the test using the Max1 (Marquette, WI). The VO 2 peak was established when two of the following three criteria were met: 1) oxygen consumption plateaued with increasing workload, 2) heart rate was greater than the age-predicted maximal value, and 3) respiratory exchange ratio (RER) exceeded 1.1.
Experimental design
The subjects were admitted to the Yale University New Haven Hospital General Clinical Research Center (GCRC) the evening before the study. They received a light breakfast at 0500 h on the day of the study. The exercise protocol was started at 0900 h and consisted of 45-min bouts of running on a motor-driven treadmill (series 2000 Treadmill, Marquette, WI) at 65-70% of the athlete's predetermined peak oxygen uptake until exhaustion. The rest intervals between the exercise bouts included NMR measurements of muscular glycogen concentration and lasted about 30 min. To verify that the subjects were working at the proper intensity, oxygen uptake was measured during the first 10 min of the first interval and during the last 5 min of each running interval. Subjects were encouraged to drink water during the exercise, but were fasted during the entire exercise session and the first 5 h of the recovery period. At 1900 h the subjects were given a standard meal and remained in the GCRC until 0600 h next morning.
Intramuscular glycogen (thigh, vastus lateralis; calf, gastrocnemius/ soleus complex; forearm, flexores digitorum) and IMCL (soleus muscle) concentrations were measured before exercise (thigh, calf, and forearm muscle), after each bout of exercise (thigh muscle), at the end of the last bout of exercise (0 -2 h after exercise), and during the recovery (thigh, calf, and forearm muscle) at 4 -5 and 17-18 h after the exercise. Due to the length of each NMR measurement (30 min for each intramuscular glycogen determination, 15 min for IMCL measurement) the forearm muscle glycogen content could be measured only at 100 min after exercise in the first five subjects. To allow clear discrimination between the effects of exercise and early recovery on glycogen concentration in nonexercising muscle, an additional forearm glycogen concentration measurement was performed immediately after the last exercise bout before the remaining NMR measurements for the next four subjects.
Although it is possible that some resynthesis of glycogen and IMCL content might have occurred during the 15-to 30-min period needed for the NMR spectroscopic measurements, if such resynthesis occurs, its extent would be negligible. Maehlum et al. showed that the resynthesis of glycogen from endogenous sources after prolonged submaximal exercise is less than 2 mmol/L⅐h (10), which is in accordance with the rates of glycogen synthesis measured in the first 5 h of recovery by our study and would result in an increase in muscle glycogen concentration by approximately 1 mmol/L. This change in glycogen concentration is below the detectability of the 13 C NMR method. Blood samples were collected before breakfast (Ϫ240 min), 5 min before the start of exercise (baseline), at the end of each exercise bout (45, 90, 135, and 180 min), every hour up to 5 h of recovery, and the next morning at 0530 h before breakfast (18 h of recovery).
The control protocol was designed to study a possible effect of fasting per se on IMCL and glycogen concentrations. The subjects were given the same diet 3 days before the study and were admitted to the GCRC the evening before the study. No physical activity was allowed during this part of experiment. Breakfast and dinner were given at 0500 and 1900 h, respectively. Four sets of muscle glycogen and IMCL concentration measurements were performed starting 0800, 1400, 1800, and 0700 h the next morning. Time points were chosen according to the time course of the NMR measurements in the exercise protocol. Blood samples were collected at 0500 (before breakfast), 1000, 1200, 1400, 1700, 1900, and 0500 h the next morning.
NMR measurements
The glycogen concentration was measured by 13 C NMR spectroscopy on a 2.1-T/1-m BioSpec system (Bruker Instruments, Inc., Billerica, MA) for thigh and calf muscles and on a 4.7-T/30-cm BioSpec Products, Inc., system (Bruker Instruments, Inc.) for forearm muscle. The coils and pulse sequences used were as previously described (15, 37) . Briefly, thigh muscle glycogen was measured using a 9-cm circular 13 C coil in a transmitter/receiver regimen combined with a 12 ϫ 14-cm coplanar butterfly proton coil, which was used for shimming, scout images, and proton decoupling during 13 C acquisition. Similarly, calf muscle glycogen was measured using a 9-cm circular 13 C coil and a 16-cm coplanar concentric proton coil, whereas forearm muscle glycogen concentration was measured using a 5.1-cm circular 13 C coil with a 9 ϫ 9 cm coplanar butterfly proton coil.
For thigh and calf muscle glycogen measurements, subjects were placed in the 2.1T spectrometer in the supine position, with the volume of interest (calf or thigh muscle) in the homogeneous region of magnet on the top of the coil (calf muscle) or underneath it (thigh muscle). The magnetic field was shimmed on nonlocalized water signal (usual bandwidth at half peak height, ϳ40 Hz). Scout images were acquired to position the volume of interest. 13 C spectra of the thigh and calf muscles were obtained with a pulse-acquire sequence in two 10-min blocks consisting of 5500 scans using a 90°pulse at the coil center and a repetition time of 120 ms (38) . Decoupling at a power of 15 watts was applied at the glycogen C1 proton resonance frequency during the 25.6-ms acquisition period. A 2-cm sphere containing 13 C-enriched formic acid was used as pulse power and loading calibration between phantom and in vivo measurements. The glycogen concentration was determined by comparing the intensity of identically broadened peaks of each subject vs. that in a phantom solution containing 150 mmol/L oyster glycogen in a cast of the subject's leg (calf muscle) or in a rectangle container (thigh muscle). Spectra were line broadened, zero filled, and manually phase corrected. The baseline was manually corrected Ϯ300 Hz, and the peak area was integrated Ϯ150 Hz on either side of the [1- 13 C]glycogen resonance. Thigh muscle glycogen signal intensity was further corrected for the sensitive volume of the 13 C coil. An image of the glycogen phantom solution was acquired using a dedicated proton coil of the same size as the 13 C coil (fully relaxed gradient echo sequence with 90°excitation pulse). The sensitive volume of the image was then compared to the set of images previously recorded from each individual using the butterfly proton coil.
For measurements of forearm muscle glycogen, the right arm was stretched into the magnet bore with the forearm muscle positioned within the homogeneous volume of the magnet on top of the coil. The magnetic field was shimmed on nonlocalized water signal (usual bandwidth at half peak height, ϳ50 Hz). Scout images were acquired to position the volume of interest. The 13 C spectra of forearm muscles were obtained using a similar pulse sequence with parameters adapted to the different (4.7-T) field strength (15) . The pulse-acquire sequence with a 90°pulse in the coil center was applied; 2700 averages, with a repetition time of 120 ms and an acquisition time of 87 ms were taken in 5.5 min (15). A 0.5-cm formate sphere mounted in the coil center was used for pulse strength and loading calibration. The absolute concentration of glycogen was then calculated as described above.
The IMCL content was measured in the soleus muscle. Localized proton NMR spectra were acquired on the 2.1-T/1-m BioSpec Products, Inc. system (Bruker Instruments, Inc.) by using a 16-cm circular surface coil in a transmitter/receiver mode. The use of 1 H NMR spectroscopy for the quantitation of IMCL content was recently introduced (36) and validated in vivo (37) . Pulse sequence, data acquisition, and processing were used as previously described (39) . During the measurements, the subject remained in the supine position within the spectrometer. The gastrocnemius-soleus muscle complex of the right leg was positioned within the homogeneous volume of the magnet on top of the coil. The magnetic field was shimmed on nonlocalized water signal (usual bandwidth, ϳ40 Hz). Scout images were acquired to position the volume of interest. The STEAM sequence (40) (echo time, 30 ms; repetition time, 2 s; 128 averages; 2048 data points) complemented by a spatially localized suppression pulse centered into the adipose tissue layer was used on the volume of 1.5 ϫ 1.5 ϫ 1.5 cm 3 . Spectra were processed using the MacNuts-PPC software package (AcornNMR, Inc., Fremont, CA). Spectra were line broadened and phase and baseline corrected, and the resonances of interest were quantified using a line-fitting procedure. After correction for T 1 and T 2 relaxations, the quantitation of IMCL content was performed comparing the intensity of (CH 2 ) n ϭ (1.25 ppm) resonance to the water resonance intensity. The IMCL content is expressed as the percentage of the intensity of the water resonance.
Analytical procedures
Plasma concentrations of glucose and lactate were measured using a 2300 STAT Plus glucose and lactate analyzer (YSI, Inc., Yellow Springs, OH). Plasma immunoreactive insulin, glucagon, leptin, and ␤-endorphin concentrations were measured using commercially available double antibody RIAs (insulin: Diagnostics Systems Laboratories, Inc., Webster, TX; glucagon: ICN Biomedicals, Inc., Costa Mesa, CA; leptin: Linco Research, Inc., St. Louis, MO; ␤-endorphin: Nichols Institute Diagnostics, San Juan Capistrano, CA). Plasma concentrations of free fatty acid (FFA) were determined using a microfluorimetric method. Plasma creatine phosphokinase activity was measured using a colorimetric method (Sigma, St. Louis, MO). Oxygen consumption and CO 2 production were measured using breath by breath indirect calorimetry (Vmax29 Metabolic Monitor, Sensomedics, CA).
Data analysis
Data are presented as the mean Ϯ sem. Statistical analysis was performed using one-way repeated measures ANOVA to analyze timecourse changes in im glycogen concentration, IMCL content, and plasma metabolite and hormone concentrations. Two-way repeated measures ANOVA was used to analyze time-course differences in im glycogen concentrations among different muscle groups. In the case of significant differences over the time course, post-hoc comparisons were made using Fisher's protected least significant difference test. Differences were considered significant at P Ͻ 0.05.
Results

Exercise performance
All of the subjects completed three or four bouts of exercise. The mean total length of the run until exhaustion was 25.5 Ϯ 1.8 km in 146.2 Ϯ 6.6 min. Exhaustion was defined by the subject's inability to maintain his pace. Oxygen consumption averaged 67.4 Ϯ 0.9% of the VO 2 peak over the entire time of the exercise protocol, and the RER decreased slowly from 0.89 Ϯ 0.02 in the first 10 min to 0.82 Ϯ 0.02 (P Ͻ 0.005) at the end of exercise.
Metabolic and hormonal data
Time-course changes in plasma glucose, lactate, insulin, FFA, glucagon, ␤-endorphin, and leptin are summarized in Figs. 1 and 2 . The plasma glucose concentration (Fig. 1A) The plasma lactate concentration (Fig. 1C) increased during the first bout of exercise from 1.09 Ϯ 0.11 to 2.38 Ϯ 0.50 mmol/L (P Ͻ 0.001), then decreased but remained elevated during the exercise period and decreased quickly to fasting values of approximately 1 mmol/L during the first 60 min of recovery and remained lower than that during exercise during the whole recovery period (P Ͻ 0.05 for each recovery time point vs. all three exercise time points).
Plasma insulin concentrations ( Fig. 2A) decreased from 50 Ϯ 4 pmol/L at baseline to 31 Ϯ 2 pmol/L after the first bout of exercise (P Ͻ 0.005 vs. baseline) and 20 Ϯ 2 pmol/L after the third bout of exercise (P Ͻ 0.0001 vs. baseline). The insulin concentration remained lower during the first 5 h of recovery (P Ͻ 0.05 for all recovery time point vs. baseline). After the 18-h recovery period plasma insulin concentrations were back to baseline values (P Ͻ 0.001 for all first five recovery time points vs. 18 h of recovery time point).
Plasma glucagon concentrations (Fig. 2B) increased from 50.7 Ϯ 7.1 pg/dL at baseline to 102.6 Ϯ 20.1 pg/dL by the end of exercise (P Ͻ 0.005) and decreased to approximately 70 pg/dL by 60 min of recovery (P Ͻ 0.05 for all recovery time points vs. the end of exercise), then remained stable during the first 5 h of the recovery period. After refeeding and overnight fasting, plasma glucagon concentrations had reached the baseline value (52.7 Ϯ 7.8 pg/dL; P ϭ NS vs. baseline; P Ͻ 0.005 vs. end of exercise).
The plasma leptin concentration (Fig. 2C ) rose only slightly from 2.8 Ϯ 0.5 g/dL at baseline to 3.2 Ϯ 0.7 g/dL after the first 45 min of exercise (P ϭ NS) and then steadily declined during the remaining time of exercise and recovery. The value at 5 h of recovery (1.7 Ϯ 0.5 g/dL) was lower than that after the first bout of exercise (P Ͻ 0.05). After dinner and 12-h overnight recovery, the plasma leptin concentrations returned to baseline. To exclude the impact of gender on leptin concentration variability, only the data from the male subjects were evaluated (41, 42) .
Although no changes in serum ␤-endorphin concentrations were observed after the first two exercise bouts (Fig.  2D) , ␤-endorphin increased to 59.5 Ϯ 14.7 pg/mL at the time of exhaustion (P Ͻ 0.001 vs. baseline). A rapid decrease to 10.7 Ϯ 1.3 pg/mL was observed during the first 5 h of recovery (P Ͻ 0.0001 for all recovery time points vs. end of exercise; P ϭ NS vs. baseline and first two bouts of exercise).
As a result of apparent muscle damage through running, exercise increased the blood plasma creatine phosphokinase concentration from 8 Ϯ 1 U/mL in the basal state to 15 Ϯ 3 U/mL at the time of exhaustion, 18 Ϯ 3 U/mL at 1 h, and 23 Ϯ 5 U/mL at 5 h postexercise.
Skeletal muscle glycogen
Time-course changes in intramuscular glycogen concentrations in different muscle groups during the exercise and recovery protocol are summarized in Fig. 3A . Mean baseline glycogen concentrations were 72.9 Ϯ 4.7 mmol/L in the Performing three or four consecutive exercise sessions resulted in stepwise glycogen depletion in the thigh muscle down to about 64% of the basal value (P Ͻ 0.0001). Glycogen depletion in the calf muscle was even more profound, as glycogen concentrations averaged 37% of the resting value (P Ͻ 0.0001) after the last bout of exercise. The glycogen concentration decreased slightly in the nonexercising forearm muscles to 79.4 Ϯ 13.4 mmol/L at 11 Ϯ 1 min (n ϭ 4; P ϭ NS) and 71.6 Ϯ 6.2 mmol/L (n ϭ 9; P ϭ NS) at 103 Ϯ 4 min after exercise.
The thigh muscle glycogen concentration increased to 75% of the resting level after 4 -5 h of recovery (P Ͻ 0.005 vs. baseline), whereas almost no resynthesis of calf muscle glycogen content was measured. A subsequent decrease in glycogen concentration to 73% of the resting level was measured in the forearm muscle (P Ͻ 0.05 vs. baseline) at this time point.
After 18 h of recovery, glycogen concentrations increased to 81% (P Ͻ 0.05 vs. baseline; P Ͻ 0.05 vs. end of the exercise), 67% (P Ͻ 0.001 vs. baseline; P Ͻ 0.005 vs. end of the exercise), and 81% (P ϭ NS) of the resting levels in the thigh, calf, and forearm muscle, respectively.
One-way repeated measures ANOVA analysis confirmed that all three muscle glycogen profiles are time dependent (arm, P ϭ 0.0001; thigh and calf, P Ͻ 0.0001). Two-way repeated measures ANOVA analysis revealed that all three glycogen profiles are different from each other (arm/calf, P Ͻ 0.0001; arm/thigh, P Ͻ 0.005; thigh/calf, P Ͻ 0.0001).
In the control study (n ϭ 3) the glycogen concentration in all three studied muscle groups did not change significantly. Over the course of a 12-h fast glycogen concentrations varied from 81.9 Ϯ 11.8 to 73.2 Ϯ 11.3 mmol/L, from 92.3 Ϯ 10.9 to 89.9 Ϯ 13.3 mmol/L, and from 68.9 Ϯ 7.1 to 70.8 Ϯ 10.4 mmol/L in the thigh, calf, and forearm muscle groups, respectively.
IMCL
Time-course changes in IMCL content during the exercise and recovery protocols are summarized in Fig. 3B . Running for 2-3 h resulted in a decrease in IMCL (CH 2 ) n ϭ resonance from 1.37 Ϯ 0.14% of water resonance peak intensity in the basal state to 0.91 Ϯ 0.09% of water resonance peak intensity (P Ͻ 0.05 vs. baseline). During the recovery period the IMCL content returned to 1.15 Ϯ 0.11% after about 4 h and to 1.23 Ϯ 0.15% (P ϭ NS vs. baseline) after 17 h of recovery. A similar pattern was observed by using the CH 3-resonance peak intensity of IMCL for quantitation. The decrease observed at the end of exercise was also significant in this case (P Ͻ 0.05). One-way repeated measures ANOVA analysis confirmed that both IMCL profiles are time dependent [(CH 2 ) n ϭ resonance, P Ͻ 0.001; CH 3 -resonance, P Ͻ 0.001], whereas two-way repeated measures ANOVA analysis found no differences between these two profiles. Comparing soleus IMCL content and leg glycogen concentration time courses revealed a significant difference only in the case of the calf muscle glycogen (P Ͻ 0.05, by two-way repeated measures ANOVA).
In the control study the IMCL content in soleus muscle remained unchanged [1.02 Ϯ 0.21% of water resonance peak intensity at baseline vs. 1.11 Ϯ 0.20% of water resonance peak intensity at 12 h fast for the (CH 2 ) n ϭ resonance).
Discussion
This study examined the time course of intramuscular glycogen and IMCL utilization during prolonged submaximal running and their replenishment during the subsequent recovery period in man. The glycogen content in the active muscles decreased over the course of the exercise in a stepwise manner, which was associated with a decrease in the rate of glycogenolysis toward the end of exercise. The lower rate of muscle glycogenolysis was in good agreement with the observed decrease in the RER, reflecting a shift toward fat oxidation over the whole exercise period. Simple linear regression of RER vs. the rate of glycogenolysis in the thigh muscle revealed a significant correlation between these variables (r ϭ 0.502; P Ͻ 0.01). This suggests that even though glycogen is being continuously used as an energy substrate, with diminishing glycogen stores the lipid pools (both circulating and intramyocellular) are taking over as main substrates for energy metabolism.
These data also demonstrate that glycogen depletion is different in various working muscle groups and that it may not be the major limiting factor for exercise performance. All of the subjects terminated the exercise due to physical exhaustion, although significant glycogen concentrations (Ͼ30 mm) were left in the active muscle groups (calf and thigh). Together with psychological fatigue, obvious muscle damage caused by running plays a role in the onset of exhaustion (17, 18) . Consistent with this latter possibility, we observed a 3-fold increase in plasma creatine phosphokinase concentrations. In addition, differences in absolute glycogen depletion reflect differences in the relative workloads for active muscle groups during level running (43) . The difference in the grade of depletion found in this study is in good agreement with the results of the only invasive study on this topic (7), which showed that glycogen depletion after level running is more pronounced in the gastrocnemius than in the vastus lateralis muscle.
The observed low rates of glycogen resynthesis (calf, 0.5 mmol/L⅐h; thigh, 2.9 mmol/L⅐h) during the first 5 h of recovery compared to other postexercise studies performed under hyperinsulinemic/hyperglycemic conditions (Ref. 15, 15 .8 mmol/L⅐h; Ref. 44, 7 .2 mmol/L⅐h) can probably be explained by low plasma glucose and insulin concentrations as well as by damaged muscle cell structure resulting from exercise.
The forearm glycogen measurements demonstrate a significant decrease in glycogen content throughout the first part of the recovery period, whereas thigh and calf muscles replenished their glycogen stores. These data suggest that there is transfer of glycogen by the glucose3lactate and the glucose3alanine cycle from the resting muscle (forearm) to recovering muscles (thigh and calf) and are consistent with the arterio-venous balance studies of Wahren et al. that demonstrated a net release of lactate and alanine from the resting muscles after exercise (3, (22) (23) (24) (25) (26) .
We also assessed IMCL utilization in the calf muscles during exercise using a novel 1 H NMR approach (36, 37, 39) and demonstrated a significant decrease in IMCL content after 2-3 h of exercise. These are the first data, to our knowledge, demonstrating the utilization of IMCL during exercise noninvasively and are consistent with the respiratory exchange ratio data showing a progressive shift toward increased fat oxidation with increasing duration of exercise. No measurements of thigh muscle IMCL content were performed because of time resolution constraints. However, Costill et al. reported an approximately 30% decrease in the vastus lateralis triglyceride content during prolonged submaximal running (43) . These data are in contrast to the recent study of Rico-Sainz et al. (34) , which found no change in IMCL content in the muscle after exercise using 1 H NMR spectroscopy. It is likely that these differences can be explained by the different type, intensity, and duration of the exercise protocols.
In summary, we found, using 13 C and 1 H NMR spectroscopy techniques to noninvasively measure muscle glycogen and IMCL content during a prolonged submaximal running protocol and subsequent recovery, 1) significantly greater muscle glycogen utilization in the calf muscle group than in the thigh muscle group, 2) significant utilization of IMCL in the soleus muscle, and 3) a decrease in glycogen content in nonexercising muscle and an increase in glycogen content in recovering muscles during the postexercise phase. These latter data are consistent with the hypothesis that there is transfer of glycogen by the glucose3lactate and the glucose3alanine cycle from the resting muscle (forearm) to recovering muscles (thigh and calf) after running exercise.
